The role of this enzyme in toxoplasmosis was evident by increased parasite burdens in infected mice administered iNOS inhibitor aminoguanidine and increased susceptibility to toxoplasmosis in iNOS-deficient mice during the late phase of infection [16]. The gene discussed is NOS2; the disease is toxoplasmosis.